Showing 521-530 of 6902 results for "".
Why Has the Prevalence Rate of Autism Tripled in Recent Years?
https://reachmd.com/programs/autism-spectrum/why-has-prevalence-rate-autism-tripled-recent-years/10264/Get a closer look into how the dramatic increase in ASD diagnoses not only affects families, but also our society and economy as a whole.How Your Practice Website Provides Value and Develops Trust
https://reachmd.com/programs/healthcares-prescription-web-social-marketing/how-your-practice-website-provides-value-and-develops-trust/10093/Health providers must demonstrate value to their site readers and patients. Russ and Randy show how providing value is very, very easy.Logistical Considerations with Anti-VEGF Treatment in Wet AMD
https://reachmd.com/programs/eye-on-ocular-health/logistical-considerations-anti-vegf-wet-amd/56544/Genetic Testing in Adults with Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/genetic-testing-in-adults-with-epilepsy/32052/Appropriate treatment of adults with epilepsy requires the practitioner to be familiar with indications for genetic testing, approaches to testing, diagnostic yield, and clinical ramifications of the results.Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
https://reachmd.com/programs/cme/treat-target-transform-applying-treat-to-target-principles-in-the-management-of-generalized-myasthenia-gravis-gmg/39980/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.CAR T-Cell Therapy: New Frontiers in Diffuse Systemic Sclerosis Treatment
https://reachmd.com/programs/living-rheum/car-t-cell-therapy-new-frontiers-in-diffuse-systemic-sclerosis-treatment/30073/CD19-targeted CAR T-cell therapy may offer lasting benefits for diffuse systemic sclerosis. Here’s what you should know.Cases From the Real World: 91-Year-Old Patient With Wet AMD and a Submacular Hemorrhage
https://reachmd.com/programs/cme/Cases-From-the-Real-World-91-Year-Old-Patient-With-Wet-AMD-and-a-Submacular-Hemorrhage/33168/Hear how Drs. Danny Mammo and Ted Leng are using second-generation retinal agents to manage patients with PEDs from nAMD.What Are Your Quality Reporting Options?
https://reachmd.com/programs/perspectives-ama/what-are-your-quality-reporting-options/10133/Uncover the options available for quality reporting under Medicare’s Quality Payment Program with Koryn Rubin of the AMA.Escape the Status Trap: Improve Your Finances
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/escaping-status-trap-improve--your-finances/8131/Lots of other people get paid really well when physicians respond to status cues, but the result can be doctors who fail to accumulate enough wealth to retire. This interview will discuss the economic rewards of pushing back against society’s status expectations. Join host Dr. John Russell as he intMarketing Your Practice - Part 1
https://reachmd.com/programs/clinicians-roundtable/marketing-your-practice-part-1/442/Dr. Baum discusses ways in which physicians can improve their practices internally and the difference this makes in patient retention.